Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announces that its Spanish distributor, Sabartech, has signed an agreement to sell EarlyCDT—Lung as a screening test for the early detection of lung cancer through the hospitals and clinics of the Quirónsalud group (“Quirónsalud”)
March 26, 2019
· 3 min read